Humana Inc. (NYSE:HUM) Position Reduced by Corebridge Financial Inc.

Corebridge Financial Inc. lowered its stake in Humana Inc. (NYSE:HUM) by 14.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 30,460 shares of the insurance provider’s stock after selling 4,994 shares during the period. Corebridge Financial Inc.’s holdings in Humana were worth $7,728,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. FPC Investment Advisory Inc. bought a new stake in Humana in the fourth quarter valued at about $27,000. Centricity Wealth Management LLC acquired a new position in shares of Humana in the 4th quarter worth approximately $30,000. LFA Lugano Financial Advisors SA raised its position in shares of Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after acquiring an additional 45 shares in the last quarter. OFI Invest Asset Management bought a new position in Humana during the fourth quarter worth $33,000. Finally, Atwood & Palmer Inc. boosted its holdings in Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 60 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. JPMorgan Chase & Co. dropped their target price on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Barclays increased their price objective on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Royal Bank of Canada restated an “outperform” rating and issued a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Piper Sandler increased their price target on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Finally, Morgan Stanley reduced their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Eighteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $285.68.

Insiders Place Their Bets

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 0.37% of the stock is owned by company insiders.

Humana Trading Down 0.2 %

Shares of NYSE:HUM opened at $270.04 on Friday. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $32.59 billion, a P/E ratio of 27.14, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a 50 day moving average of $270.51 and a 200-day moving average of $274.93.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.31%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s payout ratio is currently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.